Comparison Chart Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

Delayed Deutsche Boerse AG Other stock markets 08:06:19 07/06/2024 BST			5-day change	1st Jan Change
0.3695 ^EUR	-5.50%		-22.21%	+60.65%

05-20	BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit from Longer-Term Treatment with NurOwn	CI
05-14	Brainstorm Cell Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BRAINSTORM CELL THERAPEUTICS INC.	Other Biotechnology & Medical Research	-5.50%	-22.21%	+60.65%	-86.61%	-88.28%	28.23M	-	-	-